SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. […]

CALGARY, AB – Nanalysis Scientific Corp. (the “Company”, TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, is pleased to announce the appointment of Jonathan Ladd, Werner Maas, and Steve Feick to its Board of Directors effective May 1, 2026. Mr. Ladd is an experienced technology […]

PeptiSystems, a life science company pioneering advanced manufacturing solutions for peptide and oligonucleotide drugs, has appointed Ole J. Dahlberg to its Board of Directors. The appointment reflects the company’s focus on scaling commercial operations and expanding its global presence. Uppsala, Sweden — PeptiSystems develops and commercializes flow-through synthesis instruments for peptide and oligonucleotide therapeutics. The instruments […]

SAN DIEGO — Singular Genomics Systems, Inc. today announced the appointment of John Stark as Chief Executive Officer. This leadership transition comes as Singular builds on the launch of its market-leading spatial platform and enters its next phase, focused on expanding adoption, deepening strategic partnerships, and increasing the impact of multimodal spatial data across translational research, drug development, and future […]

RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026. In this role, […]

BURLINGTON, Mass.–908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market […]

Orion HT and Orion LE extend the Orion platform from assay development through clinical trials, backed by an expanding biomarker reagent portfolio and commercial leadership focused on global growth SEATTLE — RareCyte®, a leader in precision biology products and technologies, today announced a significant expansion of its spatial proteomics portfolio with the commercial launch of […]

Former Bio-Rad EVP & CFO brings deep sector, financial, and governance experience to support Araceli’s next phase of growth  PORTLAND, Ore. — Araceli Biosciences today announced the appointment of Christine A. Tsingos to its Board of Directors, adding a seasoned public company executive with extensive experience in financial leadership, governance, and strategic growth.  Tsingos brings more than 30 years […]

Instem, a leading provider of SaaS solutions for preclinical R&D, today announced the appointment of Szczepan Baran, VMD, MS, as Chief Scientific Officer. In the role, Szczepan will lead scientific and AI strategy across in silico predictive modeling, translational safety analytics, and data-driven drug development solutions. BOSTON, USA – Instem, a leading provider of SaaS solutions […]

ArgusEye AB today announce the appointment of Sofia Håkansson Buch as its new Chief Executive Officer (CEO), marking an important step in the company’s next phase of growth. With a strong background in biopharma, Sofia will lead the company’s continued growth and commercialization of its real-time bioprocess monitoring platform. Sofia brings extensive experience from the […]